Additionally, ASGR1 interacts with longevity assurance homolog 2 (LASS2) to suppress vacuolar-type H+-ATPase (V-ATPase) activity, reducing HCC cell migration and invasion, further supporting the role of ASGR1 as a metastasis suppressor in liver cancer (93). Here, ASGR1 is linked to liver cancer.